CTSA Logomark in front of red decorative line

Transcatheter Edge-to-Edge Repair (TEER)

Mitral valve regurgitation is defined as the leakage of blood from the left ventricle to the left atrium during systole. Over time this can lead to symptoms such as shortness of breath, fatigue, and swelling. Additionally, this can result in arrythmias, worsening heart function and heart failure.

Traditionally treatment for mitral valve regurgitation required surgery to repair or replace the mitral valve. Patients with severe mitral valve regurgitation, particularly those high risk for surgery, may be candidates for transcatheter edge to edge repair (TEER). This involves using a catheter placed through the vein in a patient’s groin to deliver a device which reapproximates the two leaflet edges, thereby reducing mitral valve regurgitation.

Following the procedure most patients are discharged home within 1 to 2 days. Benefits of the procedure include: no open heart surgery, shorter hospital stays and very little physical limitations post procedure.